Nivolumab,Ipilimumab,Cabozantinib,Sunitinib,pembrolizumab
BMS,Pfizer,merck
['arca, (-arcade)']
excellent best of journals session by our own great to see representation from latam at #ascogu23 
Chief Onc fellow @incmnszmx with interest in GU maligncies and disparities in cancer care/ @ASCO volunteer and @JCOGO_ASCO Editorial Fellow/ nuts about nuts